Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Results demonstrated a remarkable 4.4kg decrease observed within just four weeks of treatment
An Oral Medication May Appeal to You If: You strongly prefer to avoid injections You can follow a consistent daily medication routine You are comfortable with ongoing medical treatment You understand that dosing instructions may be specific You are willing to attend follow-up appointments A Wegovy Injection May Appeal to You If: You prefer a once-weekly treatment schedule You are comfortable administering an injection You can follow a clinician-directed dose-escalation plan You are prepared for possible gastrointestinal effects You accept that long-term treatment may be recommended ESG May Be Worth Exploring If: You want an incisionless procedural option You have struggled to maintain weight loss with medication alone You want physical support for smaller portion sizes You prefer to avoid traditional bariatric surgery You are committed to nutrition and long-term follow-up A Combination Plan May Be Considered If: One treatment has not produced sufficient progress Weight loss has slowed after an initial response Appetite control remains difficult after a procedure Your clinician believes multiple tools may be beneficial The potential benefits justify the added cost and complexity Weight Loss Pills vs Wegovy vs ESG vs Gastric Balloon This chart provides a general comparison of common obesity treatment options
Adverse Effects and Long-Term Safety Concerns While GLP-1 receptor agonists have shown significant benefits, their widespread use is limited by potential side effects such as gastrointestinal distress, pancreatitis risk, and concerns over long-term metabolic effects
GLP-1 injections have revolutionized the treatment of obesity and type 2 diabetes, offering a powerful tool for weight management and improved metabolic health
Exenatide regulates pancreatic islet integrity and insulin sensitivity in the nonhuman primate baboon Papio hamadryas
Originally developed to manage type 2 diabetes, these medications mimic the GLP-1 hormone, which plays a key role in regulating appetite, slowing gastric emptying, and enhancing feelings of fullness
